The New Year has officially been welcomed in and EAACI is ready for an exciting 2014. In December I reflected on a positive 2013, looking back at some of the many highlights we had as an Academy. However, that is now firmly behind us and we move forward onto bigger and better things over the next 12 months.

We began 2014 by visiting the European Parliament in Brussels in an effort to promote the Written Declaration on Allergies. Skin Prick Tests were carried out on over 350 people, including a number of Members of European Parliament (MEPs), and EAACI managed to raise awareness of not only the Written Declaration but allergy as a whole. It was a worthwhile experience and our presence in itself acts as an indicator that allergic disease is starting to being taken more seriously.

This was followed up at the European Parliament in Strasbourg a week later where EAACI engaged with key decision makers once again, continuing efforts to promote the Written Declaration and keeping the main issues facing clinicians on the radar of those who can help make a difference on the political stage. We spoke to many people, making our attendance notable and helping allergic disease take a central role once again.

You can see pictures from both events on the EAACI Facebook page.

Approaching and discussing allergic disease with the EU was one of the points on my Strategic Programme and I’m glad we’re seeing fruition of it. For all the work everyone involved in the Academy does, if the burden of allergies isn’t seen as a serious issue by governments then we will never see an improvement. The Written Declaration campaign will conclude its first stage this month but that is no reason to not continue lobbying for change. Whilst the efforts made by many over the past three months have been brilliant, it is only through consistent communication that we will begin to improve the lives of allergy sufferers.

Focusing on EAACI events, we have the 12th Winter School on Basic Research in Allergy and Clinical Immunology taking place in Poiana Brasov, Romania from 30 January – 2 February. I wish the best of luck to all involved and hope it is an enjoyable meeting. Do not forget that registration for the Allergy School on Research Methods – taking place in Newcastle-upon-Tyne, UK from April 3 – 5 2014 – is still open whilst the registration and abstract submission for the Allergy School on Investigating allergic effects of environmental exposures – taking place in Brindisi, Italy from 2 – 5 July 2014 – is now open.

There is also still time to submit your abstract for the Drug Hypersensitivity Meeting – taking place in Bern, Switzerland from 9 – 12 April 2014 – with the deadline on 31 January. You can also still benefit from the early bird registration fees until 3 February.

Finally, do not forget to book your place at the 2014 EAACI Annual Congress – set to take place in Copenhagen, Denmark from 7 – 11 June, with the theme ‘Challenging Dogmas’! Abstract submission has now been completed and we expect to have, once again, the best novel science presented. So, don't forget register early to join this exciting event.

Nikos Papadopoulos
EAACI President
Last updated 29 July 2014
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback